يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"Anthony A. Golsorkhi"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 1
    Phase 1/2 dose escalation study of NUV-422, a potent inhibitor of cyclin-dependent kinases 2, 4, and 6, in recurrent or refractory (r/r) high-grade gliomas (HGG) and solid tumors

    المؤلفون: Patrick Y. Wen, Jordi Rodon Ahnert, John D. Powderly, Howard Colman, Shannon L. Matheny, Anthony A. Golsorkhi, Teeru Bihani, Yan Zhang, Thomas Joseph Kaley

    المصدر: Journal of Clinical Oncology. 40:TPS3173-TPS3173

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5bee901a5ddcdf39e99ec1a7f0a67afa
    https://doi.org/10.1200/jco.2022.40.16_suppl.tps3173

    أضف إلى المفضلة
  2. 2
    659P Rucaparib population pharmacokinetics (PPK) and exposure-response (ER) analyses in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in TRITON2

    المؤلفون: Jeremy Shapiro, Eric Voog, J. Beltman, Joshua Zhang, Anthony A. Golsorkhi, Darrin Despain, N. J. Vogelzang, Brieuc Sautois, M. Green, Simon Paul Watkins, Wassim Abida, Amita Patnaik, Raymond S. McDermott, Richard Martin Bambury, Simon Chowdhury, J. Xiao, Andrew Simmons, David Campbell, Alan H. Bryce

    المصدر: Annals of Oncology. 31:S533-S534

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Hematology, Population pharmacokinetics, Castration resistant, medicine.disease, chemistry.chemical_compound, Prostate cancer, chemistry, Internal medicine, medicine, In patient, business, Rucaparib, Exposure response

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2da6639376baa8a98308574915a4ad72
    https://doi.org/10.1016/j.annonc.2020.08.918

    أضف إلى المفضلة
  3. 3
    Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identify targetable BRCA alterations and AR resistance mechanisms

    المؤلفون: Lucas Dennis, Samantha Morley, Jeffrey S. Ross, Geoffrey R. Oxnard, Karim Fizazi, Simon Chowdhury, Anthony A. Golsorkhi, Brian M. Alexander, Andrew Simmons, Jeffrey M. Venstrom, Jon Chung, Bernard Fendler, Hanna Tukachinsky, Wassim Abida, Russell Madison, Ryon Graf, Charles J. Ryan, Andrea Loehr, Lei Zhong, Simon Paul Watkins

    المصدر: Journal of Clinical Oncology. 39:25-25

    مصطلحات موضوعية: Cancer Research, Prostate cancer, Genomic profiling, Oncology, business.industry, Circulating tumor DNA, Cancer research, Medicine, business, medicine.disease

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::eedadde60dde04b031e5649cfe5d9c2c
    https://doi.org/10.1200/jco.2021.39.6_suppl.25

    أضف إلى المفضلة
  4. 4
    Real-world evidence of treatment patterns and pharmacy costs among patients with metastatic castration-resistant prostate cancer (mCRPC) in a managed care population in the United States

    المؤلفون: Lincy S. Lal, Anthony A. Golsorkhi, Katrine L Wallace, Nicole M. Engel-Nitz, Adrienne Landsteiner, Scott Bunner, Kelvin A. Moses

    المصدر: Journal of Clinical Oncology. 38:e19319-e19319

    مصطلحات موضوعية: Oncology, Cancer Research, education.field_of_study, medicine.medical_specialty, Modalities, business.industry, Population, Cancer, Pharmacy, Disease, medicine.disease, Prostate cancer, chemistry.chemical_compound, Castration, chemistry, Internal medicine, Medicine, Managed care, business, education

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::047268bc67156a30de8b85fb2d7a8348
    https://doi.org/10.1200/jco.2020.38.15_suppl.e19319

    أضف إلى المفضلة
  5. 5
    Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2

    المؤلفون: Darrin Despain, Andrea Loehr, Akash Patnaik, Daniel P. Petrylak, Thomas S. Stanton, Wassim Abida, Robert J. Amato, Simon Chowdhury, Charles J. Ryan, Andrew Simmons, Howard I. Scher, Ivor John Percent, Raymond S. McDermott, Arif Hussain, Alan H. Bryce, Anthony A. Golsorkhi, Jingsong Zhang, Simon Paul Watkins, Nicholas J. Vogelzang, Jeremy Shapiro

    المصدر: Journal of Clinical Oncology. 37:5031-5031

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Somatic cell, medicine.disease, Germline, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, Prostate-specific antigen, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Internal medicine, PARP inhibitor, medicine, Orchiectomy, business, Rucaparib, Allele frequency, 030215 immunology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3ccdb6957972050717618f7fe70f08e5
    https://doi.org/10.1200/jco.2019.37.15_suppl.5031

    أضف إلى المفضلة
  6. 6
    The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)

    المؤلفون: E. Gez, Gedske Daugaard, Karim Fizazi, Charles J. Ryan, Simon Chowdhury, Raymond S. McDermott, J.M. Piulats Rodriguez, Simon Paul Watkins, F. Joly Lobbedez, J.A. Arranz Arija, Srikala S. Sridhar, Wassim Abida, Axel S. Merseburger, Brieuc Sautois, Anthony A. Golsorkhi, Axel Heidenreich, Andrew Simmons, Cora N. Sternberg, S. Shetty, Howard I. Scher

    المصدر: Annals of Oncology. 28:v291

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Hematology, Castration resistant, medicine.disease, Clinical trial, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 030104 developmental biology, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Internal medicine, PARP inhibitor, Medicine, In patient, Rucaparib, business, Homologous Recombination Deficiency

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8e7121dc7d6d66e20cc2425f9c34fc4e
    https://doi.org/10.1093/annonc/mdx370.053

    أضف إلى المفضلة
  7. 7
    Trial of rucaparib in prostate indications 3 (TRITON3): An international, multicenter, randomized, open-label phase 3 study of rucaparib vs physician’s choice of therapy for patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)

    المؤلفون: Darrin Despain, Simon Paul Watkins, Chris Karlovich, Charles J. Ryan, Andrew Simmons, Anthony A. Golsorkhi, Simon Chowdhury

    المصدر: Journal of Clinical Oncology. 35:TPS5087-TPS5087

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.drug_class, 030232 urology & nephrology, Phases of clinical research, macromolecular substances, Castration resistant, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Prostate, Internal medicine, medicine, Enzalutamide, Rucaparib, business.industry, Androgen, medicine.disease, medicine.anatomical_structure, chemistry, 030220 oncology & carcinogenesis, Homologous Recombination Deficiency, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::06d06cd605020bd388db8a970ccd9c14
    https://doi.org/10.1200/jco.2017.35.15_suppl.tps5087

    أضف إلى المفضلة
  8. 8
    Fluorescence evidence for cholesterol regular distribution in phosphatidylcholine and in sphingomyeline lipid bilayers

    المؤلفون: Fang Liu, Rhoderick E. Brown, Khanh Truong, Mei Mei Wang, Anthony A. Golsorkhi, Parkson Lee-Gau Chong, Istvan P. Sugar

    المصدر: SPIE Proceedings.

    مصطلحات موضوعية: chemistry.chemical_compound, Crystallography, chemistry, Bilayer, Phosphatidylcholine, Phospholipid, lipids (amino acids, peptides, and proteins), Cholesterol analog, Lipid bilayer, Mole fraction, Sphingomyelin, Sterol

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b388be0bcdf5c1b485b7fe5c5b4ef629
    https://doi.org/10.1117/12.236184

    أضف إلى المفضلة
  9. 9
    مؤتمر

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain.

    المؤلفون: Passik SD; Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Messina J; Cephalon, Inc., Frazer, Pennsylvania, USA., Golsorkhi A; Cephalon, Inc., Frazer, Pennsylvania, USA., Xie F; Cephalon, Inc., Frazer, Pennsylvania, USA.

    المصدر: Journal of pain and symptom management [J Pain Symptom Manage] 2011 Jan; Vol. 41 (1), pp. 116-25. Date of Electronic Publication: 2010 Jul 01.

    نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

    بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8605836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6513 (Electronic) Linking ISSN: 08853924 NLM ISO Abbreviation: J Pain Symptom Manage Subsets: MEDLINE

    مواضيع طبية MeSH: Analgesics, Opioid/*administration & dosage , Breakthrough Pain/*drug therapy , Breakthrough Pain/*prevention & control , Chronic Pain/*drug therapy , Chronic Pain/*prevention & control , Fentanyl/*administration & dosage , Opioid-Related Disorders/*epidemiology, Administration, Oral ; Adolescent ; Adult ; Aged ; Causality ; Clinical Trials as Topic/statistics & numerical data ; Comorbidity ; Delayed-Action Preparations ; Female ; Humans ; Incidence ; Internationality ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Tablets ; Treatment Outcome ; Young Adult

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء